Moderna Ships 100 Millionth Dose of COVID-19 Vaccine to the U.S. Government

We are proud to announce today that Moderna has shipped the 100 millionth dose of the Moderna COVID-19 Vaccine to the United States government. This is a most heartening milestone.

In a year that has been both historic and life-changing for almost everyone, so many of us have come together across business, government and civil society to make what is proving to be a profound impact. We knew from the very beginning that no one could do this alone. The Moderna team feels a deep sense of responsibility and pride in having been able to be part of the solution.

Thank you to the many millions of people who have already put their confidence and trust in Moderna’s science and in our COVID-19 vaccine. You are our friends, our family, our coworkers, our neighbors, and we are humbled by the opportunity to help you. We are extremely grateful to the tens of thousands of participants in our clinical studies, as well as the staff at clinical trial sites who have been on the front lines of the fight against the virus.

Special thanks to our dedicated team of employees, to our suppliers, to our collaborators in the government and to our U.S. manufacturing partners, Lonza and Catalent, for extraordinary, tireless work. We are grateful to have worked with you as we have sought to combat this pandemic. 

In 10 years since our inception, Moderna has focused on our Mission to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients. We have advanced messenger RNA (mRNA) technology from the realm of revolutionary scientific possibility, to commercial production at unprecedented speed and scale.

It is our responsibility as an industry, as a company, and as global citizens to work together to try to end this pandemic, and to continue to save and improve lives. There is still far to go and much to do in the fight against this devastating virus. Along with our partners, our teams are working as hard as we can to manufacture with high quality as many doses of the vaccine as possible because we know that each additional dose we make will be used to protect one more life.

We are continuing to ramp up production and expect to deliver 40-50 million more doses per month to the U.S. government in April, May, June and July, in keeping with our commitments. We are working diligently to ramp up our supplies outside of the U.S. as well.

We remain committed to defeating the global COVID-19 pandemic. There is also far to go, and much for us to do as a company in addressing other diseases. We are closer than ever before to launching several first-in-class medicines for patients where there are no treatments today.

Thank you for your trust and support.